Nolet Chris - Insider Non-Derivative Transactions at Revance Therapeutics, Inc. (RVNC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 1, 2024, Nolet Chris's relationship to Revance Therapeutics, Inc. (RVNC) is Director, and currently has 43,606 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RVNC insiders.
Data Source: SEC.
Nolet Chris - Insider Non-Derivative Transactions of RVNC Common Stock
Nolet Chris - Insider Non-Derivative Transactions at RVNC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 2, 2024 | Acquisition -- (Common Stock) | 15000 | 0 | 43606 |
| May 4, 2023 | Acquisition -- (Common Stock) | 3534 | 0 | 28606 |